Event date
  • 16.75 ABIM MOC II
  • 16.75 ABS Accredited CME
  • 16.75 AMA PRA Category 1 Credit™
  • 16.75 Nursing Contact Hours
  • 16.75 Participation
THIS IS A HYBRID COURSECurrent treatment strategies for patients with complex digestive disorders continue to evolve.  This is largely the result of growing technological advances in surgery and endoscopy. The goal of the Minimally Invasive and Novel Therapeutics (MINT) course is to inform physicians on how best to incorporate these technologies into their practice. Using a video-based format, our goal is technique transfer from world-renowned faculty to the community, hospital, endoscopy suite, and operating room.
  • Oncology
  • 7.25 AMA PRA Category 1 Credit™
  • 7.25 Nursing Contact Hours
  • 7.25 Participation
This is a Hybrid Course Staying abreast of the rapidly advancing field of prostate imaging is paramount to the successful staging and treatment of patients with prostate cancer.
  • Hematology
  • Oncology
  • 13.50 ABIM MOC II
  • 13.50 AMA PRA Category 1 Credit™
  • 13.50 Nursing Contact Hours
  • 13.50 Participation
Please Note:This course has two components you can register for. You can either register for the symposium only, Immunotherapy Toxicities session only, or both